HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation

HBeAg is a marker of HBV-activity, and HBeAg-loss predicts a favorable clinical outcome. Here, we characterize HBeAg-levels across different phases of HBV infection, their correlation with virological/biochemical markers and the virological response to anti-HBV therapy. Quantitative HBeAg (qHBeAg, D...

Descripción completa

Detalles Bibliográficos
Autores principales: Piermatteo, Lorenzo, Alkhatib, Mohammad, D’Anna, Stefano, Malagnino, Vincenzo, Bertoli, Ada, Andreassi, Eleonora, Basile, Elisa, Iuvara, Alessandra, De Cristofaro, Maria, Cappiello, Giuseppina, Cerva, Carlotta, Minichini, Carmine, Pisaturo, Mariantonietta, Starace, Mario, Coppola, Nicola, Fontana, Carla, Grelli, Sandro, Ceccherini-Silberstein, Francesca, Andreoni, Massimo, Gill, Upkar S., Kennedy, Patrick T. F., Sarmati, Loredana, Salpini, Romina, Svicher, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533134/
https://www.ncbi.nlm.nih.gov/pubmed/34680469
http://dx.doi.org/10.3390/biomedicines9101352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533134/
https://www.ncbi.nlm.nih.gov/pubmed/34680469
http://dx.doi.org/10.3390/biomedicines9101352

Ejemplares similares